Clinical Outcome of Hypomethylating Agents in Hypocellular MDS: Mayo Clinic Experience

被引：0
|
作者：
Cerquozzi, Sonia [1 ]
Alkhateeb, Hassan B. [1 ]
Binder, Moritz [2 ]
Zblewski, Darci [1 ]
Hashmi, Shahrukh K. [1 ]
Patnaik, Mrinal M. [1 ]
Hogan, William J. [1 ]
Litzow, Mark R. [1 ]
Al-Kali, Aref [1 ]
机构：
[1] Mayo Clin, Div Hematol, Rochester, MN USA
[2] Mayo Clin, Dept Internal Med, Rochester, MN USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Differential response to hypomethylating agents based on sex: a report on behalf of the MDS Clinical Research Consortium (MDS CRC)
    DeZern, Amy E.
    Zeidan, Amer M.
    Barnard, John
    Hand, Wesley
    Al Ali, Najla
    Brown, Francis
    Zimmerman, Cassie
    Roboz, Gail J.
    Garcia-Manero, Guillermo
    Steensma, David P.
    Komrokji, Rami S.
    Sekeres, Mikkael A.
    LEUKEMIA & LYMPHOMA, 2017, 58 (06) : 1325 - 1331
  • [22] Clinical Presentation, Diagnosis, Treatment, and Outcome of Patients with Erdheim-Chester Disease: The Mayo Clinic Experience
    Shah, Mithun Vinod
    Call, Timothy G.
    Hook, Carl C.
    Johnston, Patrick B.
    Letendre, Louis
    Colgan, Joseph P.
    Pardanani, Animesh
    Clarke, Bart L.
    Grogg, Karen L.
    Go, Ronald S.
    BLOOD, 2014, 124 (21)
  • [23] Prognostic Factors and Response to the Hypomethylating Agents in Hypocellular Myelodysplastic Syndromes: A Retrospective Study from the Korean Society of Hematology AML/MDS Working Party
    Jo, Jungmin
    Bae, Sung Hwa
    Park, Jinny
    Lee, Hong-ghi
    Choi, Chul Won
    Park, Yong
    Lee, Ho Sup
    Kim, Sung-Hyun
    Lee, Won-Sik
    Bang, Soo-Mee
    Jang, Jun-Ho
    Kim, Inho
    Lee, Je-Hwan
    Cheong, June-Won
    Park, Seong Kyu
    Won, Jong-Ho
    Kim, Min Kyoung
    Shim, Hyeok
    Mun, Yeung-Chul
    Ahn, Jae-Sook
    Jo, Deog-Yeon
    Zang, Dae Young
    BLOOD, 2017, 130
  • [24] The use of acamprosate in a clinical population: Initial Mayo clinic experience
    Hall-Flavin, D.
    Karpyak, V.
    Weg, M. Vander
    Schneekloth, T.
    Mrazek, D.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (06) : 106A - 106A
  • [25] Clinical Features of Patients with Tumoral Calcinosis: The Mayo Clinic Experience
    Sfeir, Jad
    Kennel, Kurt
    Drake, Matthew
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 123 - 123
  • [26] Pachymeningitis: The Mayo Clinic Experience
    Gilbert, Emily
    Al-Awqati, Mina
    Gunderson, Tina
    Berianu, Florentina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2314 - 2316
  • [27] Camptocormia: The Mayo Clinic Experience
    Ali, Farwa
    Hassan, Anhar
    Matsumoto, Joseph Y.
    ANNALS OF NEUROLOGY, 2015, 78 : S44 - S45
  • [28] Pharmacoeconomic Evaluation of Hypomethylating Agents Used for the Treatment of MDS
    Feinberg, Bruce
    Gilmore, James
    Haislip, Sally
    Franco, Carlos M.
    Gondesen, Tom
    Saleh, Mansoor N.
    BLOOD, 2008, 112 (11) : 829 - 829
  • [29] Local verification and assignment of ISI values: recent mayo clinic experience and outcome
    Tange, I
    Grill, D.
    Koch, C.
    Ybabez, R.
    Krekelberg, B. J.
    Wiese, C.
    Block, D. R.
    Karon, B.
    Chen, D.
    Pruthi, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 577 - 578
  • [30] MEDULLOBLASTOMA - PROGNOSTIC FACTORS AND OUTCOME OF TREATMENT - REVIEW OF THE MAYO-CLINIC EXPERIENCE
    GARTON, GR
    SCHOMBERG, PJ
    SCHEITHAUER, BW
    SHAW, EG
    ILSTRUP, DM
    BLACKWELL, CR
    LAWS, ER
    EARLE, JD
    MAYO CLINIC PROCEEDINGS, 1990, 65 (08) : 1077 - 1086
12345